- President Donald Trump and Vice President Mike Pence had been major supporters of the “right-to-try” legislation, which would bypass drug regulators to give gravely ill patients access to experimental medicines.
- Proponents say this gives patients hope they would not otherwise have.
- Critics say the legislation undermines the FDA’s authority to regulate drugs and could leave patients vulnerable to medicines that might not work or may even be harmful.
Last Weekend, Iran Changed Everything
On April 13, Iran responded to Israel’s attack on its embassy compound in Damascus that killed seven Iranian officers, including a very senior military official, General Mohammad Reza Zahedi, by launching over 300 drones and missiles at Israel from Iranian soil. U.S....